Resource Center
Resource Center
This World Hepatitis Day, even as we pivot to respond to COVID-19, we cannot neglect the ongoing needs of people with chronic illnesses, such as viral hepatitis.
Read more
The report provides an overview of the supplier landscape for WHO recommended drugs and diagnostics, outlines supply and pricing trends, highlights global benchmark prices, and suggests ways in which low- and middle-income countries can access testing and treatment at more affordable prices.
Read more
CHAI is proud of the progress that we have made over the past year to address health issues in low- and middle-income countries. We have not made that progress alone. We work closely with governments, other organizations and community groups, as well as the private sector, to save lives and reduce the burden of...
Read more
The theme for the 2018 Annual Report is ‘Our Approach in Action’. There are examples in each program section of a time that CHAI’s approach was successfully applied to support our partners toward our mission.
Read more
Since launching its viral hepatitis program, Rwanda has taken an aggressive approach to combating the disease. By the end of 2018, around 700,000 people were screened for HCV and 10,000 treated and cured.
Read more
The 2017 Annual Report looks back at what we have accomplished over the year, as well as toward the goals that we have set for each of our programs over the next five to 10 years.
Read more
As we welcome another World Hepatitis Day, the global response to eliminate viral hepatitis as a public threat is accelerating. Viral hepatitis, consisting of hepatitis B (HBV) and hepatitis C (HCV), affects more than 320 million people worldwide, with 90 percent of infections concentrated in low- and middle-income countries. The disease leads to significant liver...
Read more
Amsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the spread of disease, and reduces healthcare spending. The new agreement, announced today at the 2018 International AIDS Conference,...
Read more
In Vietnam, a million people are infected with Hepatitis C (HCV). Without treatment, HCV can cause cirrhosis, liver cancer and even death. While no vaccines exist to prevent HCV, the virus is easily treated with directly-acting antivirals (DAAs). In 2017, CHAI worked with the Vietnamese government to pilot a national public sector HCV care and...
Read more
As low- and middle-income countries (LMICs) set their sights on the global elimination of hepatitis C virus (HCV) by 2030, adoption of WHO recommendations for diagnosis and improved access to testing will be critical. We believe that better market intelligence will lower supply- and demand-side barriers and help to eliminate HCV for good. This is...
Read more